Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,470 | 18,290 | 24,490 | 28,360 | 35,340 |
| Marketable Securities | 1,860 | 1,840 | 1,940 | 1,920 | 1,950 |
| Receivables | 40 | 30 | 100 | 30 | 40 |
| Other current assets | 570 | 280 | 360 | 470 | 560 |
| TOTAL | $17,940 | $20,440 | $26,890 | $30,780 | $37,890 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $18,380 | $20,900 | $27,410 | $31,320 | $38,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,360 | 4,380 | 5,830 | 4,720 | 5,300 |
| TOTAL | $3,360 | $4,380 | $5,830 | $4,720 | $5,300 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,360 | $4,380 | $5,830 | $4,720 | $5,300 |
| Shareholders' Equity | |||||
| Common Shares | 212,990 | 208,590 | 222,070 | 219,940 | 223,390 |
| Retained earnings | -221,470 | -214,970 | -224,730 | -217,090 | -214,520 |
| Other shareholders' equity | 80 | 60 | 440 | 370 | 420 |
| TOTAL | $15,010 | $16,520 | $21,570 | $26,590 | $33,080 |
| Total Liabilities And Equity | $18,370 | $20,900 | $27,400 | $31,310 | $38,380 |